Abstract
Chromatin modifications, such as reversible histone acetylation, play a key role in the regulation of T cell development and function. However, the role of individual histone deacetylases (HDACs) in T cells is less well understood. In this article, we show by conditional gene targeting that T cell-specific loss of HDAC1 led to an increased inflammatory response in an in vivo allergic airway inflammation model. Mice with HDAC1-deficient T cells displayed an increase in all critical parameters in this Th2-type asthma model, such as eosinophil recruitment into the lung, mucus hypersecretion, parenchymal lung inflammation, and enhanced airway resistance. This correlated with enhanced Th2 cytokine production in HDAC1-deficient T cells isolated from diseased mice. In vitro-polarized HDAC1-deficient Th2 cells showed a similar enhancement of IL-4 expression, which was evident already at day 3 of Th2 differentiation cultures and restricted to T cell subsets that underwent several rounds of cell divisions. HDAC1 was recruited to the Il4 gene locus in ex vivo isolated nonstimulated CD4+ T cells, indicating a direct control of the Il4 gene locus. Our data provide genetic evidence that HDAC1 is an essential HDAC that controls the magnitude of an inflammatory response by modulating cytokine expression in effector T cells.
Footnotes
Work in the laboratory of W.E. was supported by the START program (Grant Y-163) of the Austrian Science Fund and the Austrian Ministry of Science and Research, by the Austrian Science Fund (SFB-F2305 and P19930), by the Austrian Science Fund/Medical University of Vienna doctoral program (DK W1212) “Inflammation and Immunity,” and by the Vienna Science and Technology Fund (LS09-031). Work in the laboratory of C.S. was supported by the Austrian Science Fund (P18746 and P16443) and the Genome Research in Austria project “Epigenetic Plasticity of the Mammalian Genome” (Austrian Ministry of Science and Research). Work in the laboratory of P.M. was supported by the Novartis Research Foundation. R.G. was a fellow of the Vienna Biocenter International Ph.D. program supported by the Austrian Science Fund.
- Received November 6, 2009.
- Accepted July 17, 2010.